APO Research
Talk to an analyst

APO RESEARCH · REPORT

Generic Nifedipine Controlled-release Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Generic Nifedipine Controlled-release Tablets Market Analysis and Forecast 2026-2032

29 December 2025191 pages

Choose your research edition.

Industry ResearchGeneric Nifedipine Controlled-release Tablets Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Generic Nifedipine Controlled-release Tablets Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Generic Nifedipine Controlled-release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Generic Nifedipine Controlled-release Tablets Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Generic Nifedipine Controlled-release Tablets Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Generic Nifedipine Controlled-release Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Generic Nifedipine Controlled-release Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Generic Nifedipine Controlled-release Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Generic Nifedipine Controlled-release Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Generic Nifedipine Controlled-release Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Generic Nifedipine Controlled-release Tablets include Simcere, Shanghai Shyndec Pharma, Qingdao Baiyang Pharmaceutical, Hefei Cube Pharma, Nanjing Easeheal Pharma, Deyao Pharma, CR DOUBLE-CRANE, Beijing Honglin Pharma and Apichope, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Generic Nifedipine Controlled-release Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Generic Nifedipine Controlled-release Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Generic Nifedipine Controlled-release Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Generic Nifedipine Controlled-release Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Generic Nifedipine Controlled-release Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Generic Nifedipine Controlled-release Tablets sales, projected growth trends, production technology, application and end-user industry.

Generic Nifedipine Controlled-release Tablets Segment by Company

Simcere

Shanghai Shyndec Pharma

Qingdao Baiyang Pharmaceutical

Hefei Cube Pharma

Nanjing Easeheal Pharma

Deyao Pharma

CR DOUBLE-CRANE

Beijing Honglin Pharma

Apichope

Generic Nifedipine Controlled-release Tablets Segment by Type

30mg per Tablet

60mg per Tablet

Generic Nifedipine Controlled-release Tablets Segment by Application

Hypertension

Exertional Angina

Other

Generic Nifedipine Controlled-release Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Generic Nifedipine Controlled-release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Generic Nifedipine Controlled-release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Generic Nifedipine Controlled-release Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Generic Nifedipine Controlled-release Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Generic Nifedipine Controlled-release Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Generic Nifedipine Controlled-release Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Generic Nifedipine Controlled-release Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 30mg per Tablet Major Manufacturers Table 3. 60mg per Tablet Major Manufacturers Table 4. Global Generic Nifedipine Controlled-release Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hypertension Major Manufacturers Table 6. Exertional Angina Major Manufacturers Table 7. Other Major Manufacturers Table 8. Generic Nifedipine Controlled-release Tablets Industry Trends Table 9. Generic Nifedipine Controlled-release Tablets Industry Drivers Table 10. Generic Nifedipine Controlled-release Tablets Industry Opportunities and Challenges Table 11. Generic Nifedipine Controlled-release Tablets Industry Restraints Table 12. Global Generic Nifedipine Controlled-release Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Generic Nifedipine Controlled-release Tablets Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Generic Nifedipine Controlled-release Tablets Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Region (2021-2026) Table 16. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Region (2027-2032) Table 17. Global Generic Nifedipine Controlled-release Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Generic Nifedipine Controlled-release Tablets Sales by Region (2021-2026) & (K Units) Table 19. Global Generic Nifedipine Controlled-release Tablets Sales by Region (2027-2032) & (K Units) Table 20. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Region (2021-2026) Table 21. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Region (2027-2032) Table 22. Global Generic Nifedipine Controlled-release Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Generic Nifedipine Controlled-release Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Manufacturers (2021-2026) Table 26. Global Generic Nifedipine Controlled-release Tablets Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Generic Nifedipine Controlled-release Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Generic Nifedipine Controlled-release Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Generic Nifedipine Controlled-release Tablets Manufacturers, Product Type & Application Table 30. Global Generic Nifedipine Controlled-release Tablets Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Generic Nifedipine Controlled-release Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Generic Nifedipine Controlled-release Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Generic Nifedipine Controlled-release Tablets Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Generic Nifedipine Controlled-release Tablets Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Type (2021-2026) Table 37. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Type (2027-2032) Table 38. Global Generic Nifedipine Controlled-release Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Generic Nifedipine Controlled-release Tablets Sales by Type (2021-2026) & (K Units) Table 40. Global Generic Nifedipine Controlled-release Tablets Sales by Type (2027-2032) & (K Units) Table 41. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Type (2021-2026) Table 42. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Type (2027-2032) Table 43. Global Generic Nifedipine Controlled-release Tablets Price by Type (2021-2026) & (US$/Unit) Table 44. Global Generic Nifedipine Controlled-release Tablets Price by Type (2027-2032) & (US$/Unit) Table 45. Global Generic Nifedipine Controlled-release Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Generic Nifedipine Controlled-release Tablets Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Generic Nifedipine Controlled-release Tablets Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Application (2021-2026) Table 49. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Application (2027-2032) Table 50. Global Generic Nifedipine Controlled-release Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Generic Nifedipine Controlled-release Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Generic Nifedipine Controlled-release Tablets Sales by Application (2027-2032) & (K Units) Table 53. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Application (2021-2026) Table 54. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Application (2027-2032) Table 55. Global Generic Nifedipine Controlled-release Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Generic Nifedipine Controlled-release Tablets Price by Application (2027-2032) & (US$/Unit) Table 57. Simcere Company Information Table 58. Simcere Business Overview Table 59. Simcere Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Simcere Generic Nifedipine Controlled-release Tablets Product Portfolio Table 61. Simcere Recent Development Table 62. Shanghai Shyndec Pharma Company Information Table 63. Shanghai Shyndec Pharma Business Overview Table 64. Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio Table 66. Shanghai Shyndec Pharma Recent Development Table 67. Qingdao Baiyang Pharmaceutical Company Information Table 68. Qingdao Baiyang Pharmaceutical Business Overview Table 69. Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Product Portfolio Table 71. Qingdao Baiyang Pharmaceutical Recent Development Table 72. Hefei Cube Pharma Company Information Table 73. Hefei Cube Pharma Business Overview Table 74. Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio Table 76. Hefei Cube Pharma Recent Development Table 77. Nanjing Easeheal Pharma Company Information Table 78. Nanjing Easeheal Pharma Business Overview Table 79. Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio Table 81. Nanjing Easeheal Pharma Recent Development Table 82. Deyao Pharma Company Information Table 83. Deyao Pharma Business Overview Table 84. Deyao Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Deyao Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio Table 86. Deyao Pharma Recent Development Table 87. CR DOUBLE-CRANE Company Information Table 88. CR DOUBLE-CRANE Business Overview Table 89. CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Product Portfolio Table 91. CR DOUBLE-CRANE Recent Development Table 92. Beijing Honglin Pharma Company Information Table 93. Beijing Honglin Pharma Business Overview Table 94. Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio Table 96. Beijing Honglin Pharma Recent Development Table 97. Apichope Company Information Table 98. Apichope Business Overview Table 99. Apichope Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Apichope Generic Nifedipine Controlled-release Tablets Product Portfolio Table 101. Apichope Recent Development Table 102. North America Generic Nifedipine Controlled-release Tablets Revenue by Type (2021-2026) & (US$ Million) Table 103. North America Generic Nifedipine Controlled-release Tablets Revenue by Type (2027-2032) & (US$ Million) Table 104. North America Generic Nifedipine Controlled-release Tablets Sales by Type (2021-2026) & (K Units) Table 105. North America Generic Nifedipine Controlled-release Tablets Sales by Type (2027-2032) & (K Units) Table 106. North America Generic Nifedipine Controlled-release Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 107. North America Generic Nifedipine Controlled-release Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 108. North America Generic Nifedipine Controlled-release Tablets Revenue by Application (2021-2026) & (US$ Million) Table 109. North America Generic Nifedipine Controlled-release Tablets Revenue by Application (2027-2032) & (US$ Million) Table 110. North America Generic Nifedipine Controlled-release Tablets Sales by Application (2021-2026) & (K Units) Table 111. North America Generic Nifedipine Controlled-release Tablets Sales by Application (2027-2032) & (K Units) Table 112. North America Generic Nifedipine Controlled-release Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 113. North America Generic Nifedipine Controlled-release Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 114. North America Generic Nifedipine Controlled-release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Generic Nifedipine Controlled-release Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. North America Generic Nifedipine Controlled-release Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. North America Generic Nifedipine Controlled-release Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 118. North America Generic Nifedipine Controlled-release Tablets Sales by Country (2021-2026) & (K Units) Table 119. North America Generic Nifedipine Controlled-release Tablets Sales by Country (2027-2032) & (K Units) Table 120. North America Generic Nifedipine Controlled-release Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 121. North America Generic Nifedipine Controlled-release Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 122. United States Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 123. Canada Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 124. Mexico Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 125. Europe Generic Nifedipine Controlled-release Tablets Revenue by Type (2021-2026) & (US$ Million) Table 126. Europe Generic Nifedipine Controlled-release Tablets Revenue by Type (2027-2032) & (US$ Million) Table 127. Europe Generic Nifedipine Controlled-release Tablets Sales by Type (2021-2026) & (K Units) Table 128. Europe Generic Nifedipine Controlled-release Tablets Sales by Type (2027-2032) & (K Units) Table 129. Europe Generic Nifedipine Controlled-release Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 130. Europe Generic Nifedipine Controlled-release Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 131. Europe Generic Nifedipine Controlled-release Tablets Revenue by Application (2021-2026) & (US$ Million) Table 132. Europe Generic Nifedipine Controlled-release Tablets Revenue by Application (2027-2032) & (US$ Million) Table 133. Europe Generic Nifedipine Controlled-release Tablets Sales by Application (2021-2026) & (K Units) Table 134. Europe Generic Nifedipine Controlled-release Tablets Sales by Application (2027-2032) & (K Units) Table 135. Europe Generic Nifedipine Controlled-release Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 136. Europe Generic Nifedipine Controlled-release Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 137. Europe Generic Nifedipine Controlled-release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Europe Generic Nifedipine Controlled-release Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 139. Europe Generic Nifedipine Controlled-release Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 140. Europe Generic Nifedipine Controlled-release Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 141. Europe Generic Nifedipine Controlled-release Tablets Sales by Country (2021-2026) & (K Units) Table 142. Europe Generic Nifedipine Controlled-release Tablets Sales by Country (2027-2032) & (K Units) Table 143. Europe Generic Nifedipine Controlled-release Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 144. Europe Generic Nifedipine Controlled-release Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 145. Germany Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 146. France Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 147. U.K. Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 148. Italy Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 149. Russia Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 150. Spain Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 151. Netherlands Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 152. Switzerland Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 153. Sweden Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 154. Poland Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 155. China Generic Nifedipine Controlled-release Tablets Revenue by Type (2021-2026) & (US$ Million) Table 156. China Generic Nifedipine Controlled-release Tablets Revenue by Type (2027-2032) & (US$ Million) Table 157. China Generic Nifedipine Controlled-release Tablets Sales by Type (2021-2026) & (K Units) Table 158. China Generic Nifedipine Controlled-release Tablets Sales by Type (2027-2032) & (K Units) Table 159. China Generic Nifedipine Controlled-release Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 160. China Generic Nifedipine Controlled-release Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 161. China Generic Nifedipine Controlled-release Tablets Revenue by Application (2021-2026) & (US$ Million) Table 162. China Generic Nifedipine Controlled-release Tablets Revenue by Application (2027-2032) & (US$ Million) Table 163. China Generic Nifedipine Controlled-release Tablets Sales by Application (2021-2026) & (K Units) Table 164. China Generic Nifedipine Controlled-release Tablets Sales by Application (2027-2032) & (K Units) Table 165. China Generic Nifedipine Controlled-release Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 166. China Generic Nifedipine Controlled-release Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 167. Asia Generic Nifedipine Controlled-release Tablets Revenue by Type (2021-2026) & (US$ Million) Table 168. Asia Generic Nifedipine Controlled-release Tablets Revenue by Type (2027-2032) & (US$ Million) Table 169. Asia Generic Nifedipine Controlled-release Tablets Sales by Type (2021-2026) & (K Units) Table 170. Asia Generic Nifedipine Controlled-release Tablets Sales by Type (2027-2032) & (K Units) Table 171. Asia Generic Nifedipine Controlled-release Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 172. Asia Generic Nifedipine Controlled-release Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 173. Asia Generic Nifedipine Controlled-release Tablets Revenue by Application (2021-2026) & (US$ Million) Table 174. Asia Generic Nifedipine Controlled-release Tablets Revenue by Application (2027-2032) & (US$ Million) Table 175. Asia Generic Nifedipine Controlled-release Tablets Sales by Application (2021-2026) & (K Units) Table 176. Asia Generic Nifedipine Controlled-release Tablets Sales by Application (2027-2032) & (K Units) Table 177. Asia Generic Nifedipine Controlled-release Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 178. Asia Generic Nifedipine Controlled-release Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 179. Asia Generic Nifedipine Controlled-release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. Asia Generic Nifedipine Controlled-release Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. Asia Generic Nifedipine Controlled-release Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. Asia Generic Nifedipine Controlled-release Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 183. Asia Generic Nifedipine Controlled-release Tablets Sales by Country (2021-2026) & (K Units) Table 184. Asia Generic Nifedipine Controlled-release Tablets Sales by Country (2027-2032) & (K Units) Table 185. Asia Generic Nifedipine Controlled-release Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 186. Asia Generic Nifedipine Controlled-release Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 187. Japan Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 188. South Korea Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 189. India Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 190. Australia Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 191. Taiwan Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 192. Southeast Asia Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 193. SAMEA Generic Nifedipine Controlled-release Tablets Revenue by Type (2021-2026) & (US$ Million) Table 194. SAMEA Generic Nifedipine Controlled-release Tablets Revenue by Type (2027-2032) & (US$ Million) Table 195. SAMEA Generic Nifedipine Controlled-release Tablets Sales by Type (2021-2026) & (K Units) Table 196. SAMEA Generic Nifedipine Controlled-release Tablets Sales by Type (2027-2032) & (K Units) Table 197. SAMEA Generic Nifedipine Controlled-release Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 198. SAMEA Generic Nifedipine Controlled-release Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 199. SAMEA Generic Nifedipine Controlled-release Tablets Revenue by Application (2021-2026) & (US$ Million) Table 200. SAMEA Generic Nifedipine Controlled-release Tablets Revenue by Application (2027-2032) & (US$ Million) Table 201. SAMEA Generic Nifedipine Controlled-release Tablets Sales by Application (2021-2026) & (K Units) Table 202. SAMEA Generic Nifedipine Controlled-release Tablets Sales by Application (2027-2032) & (K Units) Table 203. SAMEA Generic Nifedipine Controlled-release Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 204. SAMEA Generic Nifedipine Controlled-release Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 205. SAMEA Generic Nifedipine Controlled-release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 206. SAMEA Generic Nifedipine Controlled-release Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 207. SAMEA Generic Nifedipine Controlled-release Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 208. SAMEA Generic Nifedipine Controlled-release Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 209. SAMEA Generic Nifedipine Controlled-release Tablets Sales by Country (2021-2026) & (K Units) Table 210. SAMEA Generic Nifedipine Controlled-release Tablets Sales by Country (2027-2032) & (K Units) Table 211. SAMEA Generic Nifedipine Controlled-release Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 212. SAMEA Generic Nifedipine Controlled-release Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 213. Brazil Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 214. Argentina Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 215. Chile Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 216. Colombia Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 217. Peru Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 218. Saudi Arabia Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 219. Israel Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 220. UAE Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 221. Turkey Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 222. Iran Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 223. Egypt Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Table 224. Key Raw Materials Table 225. Raw Materials Key Suppliers Table 226. Generic Nifedipine Controlled-release Tablets Distributors List Table 227. Generic Nifedipine Controlled-release Tablets Customers List Table 228. Research Programs/Design for This Report Table 229. Authors List of This Report Table 230. Secondary Sources Table 231. Primary Sources List of Figures Figure 1. Generic Nifedipine Controlled-release Tablets Image Figure 2. Global Generic Nifedipine Controlled-release Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Generic Nifedipine Controlled-release Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. 30mg per Tablet Image Figure 5. 60mg per Tablet Image Figure 6. Global Generic Nifedipine Controlled-release Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Generic Nifedipine Controlled-release Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hypertension Image Figure 9. Exertional Angina Image Figure 10. Other Image Figure 11. Global Generic Nifedipine Controlled-release Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Figure 13. Global Generic Nifedipine Controlled-release Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Region (2021-2032) Figure 16. Global Generic Nifedipine Controlled-release Tablets Sales (2021-2032) & (K Units) Figure 17. Global Generic Nifedipine Controlled-release Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Generic Nifedipine Controlled-release Tablets Sales YoY (2021-2032) & (K Units) Figure 20. Europe Generic Nifedipine Controlled-release Tablets Sales YoY (2021-2032) & (K Units) Figure 21. China Generic Nifedipine Controlled-release Tablets Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Generic Nifedipine Controlled-release Tablets Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Generic Nifedipine Controlled-release Tablets Sales YoY (2021-2032) & (K Units) Figure 24. Global Generic Nifedipine Controlled-release Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Generic Nifedipine Controlled-release Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Generic Nifedipine Controlled-release Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Type (2021-2032) Figure 30. Global Generic Nifedipine Controlled-release Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Type (2021-2032) Figure 33. Global Generic Nifedipine Controlled-release Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Application (2021-2032) Figure 36. Global Generic Nifedipine Controlled-release Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Application (2021-2032) Figure 39. North America Generic Nifedipine Controlled-release Tablets Revenue Share by Type (2021-2032) Figure 40. North America Generic Nifedipine Controlled-release Tablets Sales Share by Type (2021-2032) Figure 41. North America Generic Nifedipine Controlled-release Tablets Revenue Share by Application (2021-2032) Figure 42. North America Generic Nifedipine Controlled-release Tablets Sales Share by Application (2021-2032) Figure 43. North America Generic Nifedipine Controlled-release Tablets Revenue Share by Country (2021-2032) Figure 44. North America Generic Nifedipine Controlled-release Tablets Sales Share by Country (2021-2032) Figure 45. Europe Generic Nifedipine Controlled-release Tablets Revenue Share by Type (2021-2032) Figure 46. Europe Generic Nifedipine Controlled-release Tablets Sales Share by Type (2021-2032) Figure 47. Europe Generic Nifedipine Controlled-release Tablets Revenue Share by Application (2021-2032) Figure 48. Europe Generic Nifedipine Controlled-release Tablets Sales Share by Application (2021-2032) Figure 49. Europe Generic Nifedipine Controlled-release Tablets Revenue Share by Country (2021-2032) Figure 50. Europe Generic Nifedipine Controlled-release Tablets Sales Share by Country (2021-2032) Figure 51. China Generic Nifedipine Controlled-release Tablets Revenue Share by Type (2021-2032) Figure 52. China Generic Nifedipine Controlled-release Tablets Sales Share by Type (2021-2032) Figure 53. China Generic Nifedipine Controlled-release Tablets Revenue Share by Application (2021-2032) Figure 54. China Generic Nifedipine Controlled-release Tablets Sales Share by Application (2021-2032) Figure 55. Asia Generic Nifedipine Controlled-release Tablets Revenue Share by Type (2021-2032) Figure 56. Asia Generic Nifedipine Controlled-release Tablets Sales Share by Type (2021-2032) Figure 57. Asia Generic Nifedipine Controlled-release Tablets Revenue Share by Application (2021-2032) Figure 58. Asia Generic Nifedipine Controlled-release Tablets Sales Share by Application (2021-2032) Figure 59. Asia Generic Nifedipine Controlled-release Tablets Revenue Share by Country (2021-2032) Figure 60. Asia Generic Nifedipine Controlled-release Tablets Sales Share by Country (2021-2032) Figure 61. SAMEA Generic Nifedipine Controlled-release Tablets Revenue Share by Type (2021-2032) Figure 62. SAMEA Generic Nifedipine Controlled-release Tablets Sales Share by Type (2021-2032) Figure 63. SAMEA Generic Nifedipine Controlled-release Tablets Revenue Share by Application (2021-2032) Figure 64. SAMEA Generic Nifedipine Controlled-release Tablets Sales Share by Application (2021-2032) Figure 65. SAMEA Generic Nifedipine Controlled-release Tablets Revenue Share by Country (2021-2032) Figure 66. SAMEA Generic Nifedipine Controlled-release Tablets Sales Share by Country (2021-2032) Figure 67. Generic Nifedipine Controlled-release Tablets Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Generic Nifedipine Controlled-release Tablets Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 30mg per Tablet
  • 60mg per Tablet
Applications
  • Hypertension
  • Exertional Angina
  • Other
Companies covered
  • Simcere
  • Shanghai Shyndec Pharma
  • Qingdao Baiyang Pharmaceutical
  • Hefei Cube Pharma
  • Nanjing Easeheal Pharma
  • Deyao Pharma
  • CR DOUBLE-CRANE
  • Beijing Honglin Pharma
  • Apichope

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Generic Nifedipine Controlled-release Tablets Market by Type
  3. 1.2.1 Global Generic Nifedipine Controlled-release Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 30mg per Tablet
  5. 1.2.3 60mg per Tablet
  6. 1.3 Generic Nifedipine Controlled-release Tablets Market by Application
  7. 1.3.1 Global Generic Nifedipine Controlled-release Tablets Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hypertension
  9. 1.3.3 Exertional Angina
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Generic Nifedipine Controlled-release Tablets Market Dynamics
  1. 2.1 Generic Nifedipine Controlled-release Tablets Industry Trends
  2. 2.2 Generic Nifedipine Controlled-release Tablets Industry Drivers
  3. 2.3 Generic Nifedipine Controlled-release Tablets Industry Opportunities and Challenges
  4. 2.4 Generic Nifedipine Controlled-release Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Generic Nifedipine Controlled-release Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Region
  3. 3.2.1 Global Generic Nifedipine Controlled-release Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Generic Nifedipine Controlled-release Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Generic Nifedipine Controlled-release Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Generic Nifedipine Controlled-release Tablets Sales by Region
  9. 3.4.1 Global Generic Nifedipine Controlled-release Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Generic Nifedipine Controlled-release Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Generic Nifedipine Controlled-release Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Generic Nifedipine Controlled-release Tablets Revenue by Manufacturers
  2. 4.1.1 Global Generic Nifedipine Controlled-release Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Generic Nifedipine Controlled-release Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Generic Nifedipine Controlled-release Tablets Sales by Manufacturers
  6. 4.2.1 Global Generic Nifedipine Controlled-release Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Generic Nifedipine Controlled-release Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Generic Nifedipine Controlled-release Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Generic Nifedipine Controlled-release Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Generic Nifedipine Controlled-release Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Generic Nifedipine Controlled-release Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Generic Nifedipine Controlled-release Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Generic Nifedipine Controlled-release Tablets Market CR5 and HHI
  16. 4.8.2 2025 Generic Nifedipine Controlled-release Tablets Tier 1, Tier 2, and Tier 3
5 Generic Nifedipine Controlled-release Tablets Market by Type
  1. 5.1 Global Generic Nifedipine Controlled-release Tablets Revenue by Type
  2. 5.1.1 Global Generic Nifedipine Controlled-release Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Generic Nifedipine Controlled-release Tablets Sales by Type
  6. 5.2.1 Global Generic Nifedipine Controlled-release Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Generic Nifedipine Controlled-release Tablets Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Generic Nifedipine Controlled-release Tablets Price by Type
6 Generic Nifedipine Controlled-release Tablets Market by Application
  1. 6.1 Global Generic Nifedipine Controlled-release Tablets Revenue by Application
  2. 6.1.1 Global Generic Nifedipine Controlled-release Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Generic Nifedipine Controlled-release Tablets Sales by Application
  6. 6.2.1 Global Generic Nifedipine Controlled-release Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Generic Nifedipine Controlled-release Tablets Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Generic Nifedipine Controlled-release Tablets Price by Application
7 Company Profiles
  1. 7.1 Simcere
  2. 7.1.1 Simcere Company Information
  3. 7.1.2 Simcere Business Overview
  4. 7.1.3 Simcere Generic Nifedipine Controlled-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Simcere Generic Nifedipine Controlled-release Tablets Product Portfolio
  6. 7.1.5 Simcere Recent Developments
  7. 7.2 Shanghai Shyndec Pharma
  8. 7.2.1 Shanghai Shyndec Pharma Company Information
  9. 7.2.2 Shanghai Shyndec Pharma Business Overview
  10. 7.2.3 Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
  12. 7.2.5 Shanghai Shyndec Pharma Recent Developments
  13. 7.3 Qingdao Baiyang Pharmaceutical
  14. 7.3.1 Qingdao Baiyang Pharmaceutical Company Information
  15. 7.3.2 Qingdao Baiyang Pharmaceutical Business Overview
  16. 7.3.3 Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Product Portfolio
  18. 7.3.5 Qingdao Baiyang Pharmaceutical Recent Developments
  19. 7.4 Hefei Cube Pharma
  20. 7.4.1 Hefei Cube Pharma Company Information
  21. 7.4.2 Hefei Cube Pharma Business Overview
  22. 7.4.3 Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
  24. 7.4.5 Hefei Cube Pharma Recent Developments
  25. 7.5 Nanjing Easeheal Pharma
  26. 7.5.1 Nanjing Easeheal Pharma Company Information
  27. 7.5.2 Nanjing Easeheal Pharma Business Overview
  28. 7.5.3 Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
  30. 7.5.5 Nanjing Easeheal Pharma Recent Developments
  31. 7.6 Deyao Pharma
  32. 7.6.1 Deyao Pharma Company Information
  33. 7.6.2 Deyao Pharma Business Overview
  34. 7.6.3 Deyao Pharma Generic Nifedipine Controlled-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Deyao Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
  36. 7.6.5 Deyao Pharma Recent Developments
  37. 7.7 CR DOUBLE-CRANE
  38. 7.7.1 CR DOUBLE-CRANE Company Information
  39. 7.7.2 CR DOUBLE-CRANE Business Overview
  40. 7.7.3 CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Product Portfolio
  42. 7.7.5 CR DOUBLE-CRANE Recent Developments
  43. 7.8 Beijing Honglin Pharma
  44. 7.8.1 Beijing Honglin Pharma Company Information
  45. 7.8.2 Beijing Honglin Pharma Business Overview
  46. 7.8.3 Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
  48. 7.8.5 Beijing Honglin Pharma Recent Developments
  49. 7.9 Apichope
  50. 7.9.1 Apichope Company Information
  51. 7.9.2 Apichope Business Overview
  52. 7.9.3 Apichope Generic Nifedipine Controlled-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Apichope Generic Nifedipine Controlled-release Tablets Product Portfolio
  54. 7.9.5 Apichope Recent Developments
8 North America
  1. 8.1 North America Generic Nifedipine Controlled-release Tablets Market Size by Type
  2. 8.1.1 North America Generic Nifedipine Controlled-release Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Generic Nifedipine Controlled-release Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Generic Nifedipine Controlled-release Tablets Price by Type (2021-2032)
  5. 8.2 North America Generic Nifedipine Controlled-release Tablets Market Size by Application
  6. 8.2.1 North America Generic Nifedipine Controlled-release Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Generic Nifedipine Controlled-release Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Generic Nifedipine Controlled-release Tablets Price by Application (2021-2032)
  9. 8.3 North America Generic Nifedipine Controlled-release Tablets Market Size by Country
  10. 8.3.1 North America Generic Nifedipine Controlled-release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Generic Nifedipine Controlled-release Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Generic Nifedipine Controlled-release Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Generic Nifedipine Controlled-release Tablets Market Size by Type
  2. 9.1.1 Europe Generic Nifedipine Controlled-release Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Generic Nifedipine Controlled-release Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Generic Nifedipine Controlled-release Tablets Price by Type (2021-2032)
  5. 9.2 Europe Generic Nifedipine Controlled-release Tablets Market Size by Application
  6. 9.2.1 Europe Generic Nifedipine Controlled-release Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Generic Nifedipine Controlled-release Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Generic Nifedipine Controlled-release Tablets Price by Application (2021-2032)
  9. 9.3 Europe Generic Nifedipine Controlled-release Tablets Market Size by Country
  10. 9.3.1 Europe Generic Nifedipine Controlled-release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Generic Nifedipine Controlled-release Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Generic Nifedipine Controlled-release Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Generic Nifedipine Controlled-release Tablets Market Size by Type
  2. 10.1.1 China Generic Nifedipine Controlled-release Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Generic Nifedipine Controlled-release Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Generic Nifedipine Controlled-release Tablets Price by Type (2021-2032)
  5. 10.2 China Generic Nifedipine Controlled-release Tablets Market Size by Application
  6. 10.2.1 China Generic Nifedipine Controlled-release Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Generic Nifedipine Controlled-release Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Generic Nifedipine Controlled-release Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Generic Nifedipine Controlled-release Tablets Market Size by Type
  2. 11.1.1 Asia Generic Nifedipine Controlled-release Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Generic Nifedipine Controlled-release Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Generic Nifedipine Controlled-release Tablets Price by Type (2021-2032)
  5. 11.2 Asia Generic Nifedipine Controlled-release Tablets Market Size by Application
  6. 11.2.1 Asia Generic Nifedipine Controlled-release Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Generic Nifedipine Controlled-release Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Generic Nifedipine Controlled-release Tablets Price by Application (2021-2032)
  9. 11.3 Asia Generic Nifedipine Controlled-release Tablets Market Size by Country
  10. 11.3.1 Asia Generic Nifedipine Controlled-release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Generic Nifedipine Controlled-release Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Generic Nifedipine Controlled-release Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Generic Nifedipine Controlled-release Tablets Market Size by Type
  2. 12.1.1 SAMEA Generic Nifedipine Controlled-release Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Generic Nifedipine Controlled-release Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Generic Nifedipine Controlled-release Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Generic Nifedipine Controlled-release Tablets Market Size by Application
  6. 12.2.1 SAMEA Generic Nifedipine Controlled-release Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Generic Nifedipine Controlled-release Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Generic Nifedipine Controlled-release Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Generic Nifedipine Controlled-release Tablets Market Size by Country
  10. 12.3.1 SAMEA Generic Nifedipine Controlled-release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Generic Nifedipine Controlled-release Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Generic Nifedipine Controlled-release Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Generic Nifedipine Controlled-release Tablets Value Chain Analysis
  2. 13.1.1 Generic Nifedipine Controlled-release Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Generic Nifedipine Controlled-release Tablets Production Mode & Process
  6. 13.2 Generic Nifedipine Controlled-release Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Generic Nifedipine Controlled-release Tablets Distributors
  9. 13.2.3 Generic Nifedipine Controlled-release Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst